SCHEMBL24814400

SCHEMBL24814400

O=C(CSc1nccs1)N1Cc2ccc([N+](=O)[O-])cc2C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP7 Q9UHL4 1/20 0.43
▸ ALDH1A1 P00352 8/20 0.41
▸ MAPT P10636 8/20 0.41
▸ LMNA P02545 6/20 0.41
▸ POLB P06746 3/20 0.41
▸ MGAM O43451 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ SI P14410 1/20 0.41
▸ MGAM2 Q2M2H8 1/20 0.41
▸ NAMPT P43490 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ HTT P42858 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ CPT2 P23786 1/20 0.39
▸ CPT1A P50416 1/20 0.39
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24814435 0.83 HSD17B3 (0.43) ALDH1A1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL26845894 0.82 ALDH1A1 (0.41) DPP7ALDH1A1MAPTLMNAPOLB
SCHEMBL24815709 0.82 NAMPT (0.44) DPP7ALDH1A1MGAMGAASI
SCHEMBL24815712 0.82 MAOB (0.41) ALDH1A1MAPTLMNAPOLBMGAM
SCHEMBL29986261 0.81 ALDH1A1 (0.47) ALDH1A1MAPTLMNAPOLBGAA
SCHEMBL24814434 0.81 ALDH1A1 (0.47) ALDH1A1MAPTLMNAPOLBGAA
SCHEMBL24815708 0.80 ALDH1A1 (0.43) ALDH1A1MAPTLMNAMGAMGAA
SCHEMBL24815667 0.79 ALDH1A1 (0.39) ALDH1A1POLBMGAMGAASI
SCHEMBL24816166 0.79 ALDH1A1 (0.39) ALDH1A1MAPTLMNAGAASMN1; SMN2
SCHEMBL24814401 0.78 DPP7 (0.43) DPP7MAPTLMNANAMPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-29 — — US disclosed
WO-2022251343-A2 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF CISD2, CISD1, FECH DPP7 4414/4885ALDH1A1 3533/4885MAPT 4407/4885
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof CISD2, CISD1, FECH DPP7 4414/4885ALDH1A1 3533/4885MAPT 4407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback